Global Blood Therapeutics, Inc.
GBTDelisted Oct 5, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001629137
Global Blood Therapeutics, Inc. was delisted on Oct 5, 2022; its insiders filed their last Form 4 on Oct 6, 2022; 247 institutions reported holding it in 13F filings for Q3 2022, worth $4.67B in total; Soros Fund Management was the only superinvestor holding it.
Members of Congress who traded GBT
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 1
- Members
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Donna E. ShalalaDemocrat · House · FL | 2 | 1 / 1 | $16.0K | Jun 24, 2019 | Apr 27, 2020 |
Trades
Every reported trade in Global Blood Therapeutics, Inc., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Donna E. ShalalaDemocrat · House · FL | GBTGlobal Blood Therapeutics, Inc. | Sell | Self | Jun 24, 2019 | Apr 27, 2020 | 308 daysLate | $1K-$15K | Filing |
| Donna E. ShalalaDemocrat · House · FL | GBTGlobal Blood Therapeutics, Inc. | Buy | Self | Jun 4, 2019 | Apr 27, 2020 | 328 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.